Deep Tech Startups
7,090 companies tagged Deep Tech, with their investors and founders.
Matinas BioPharma develops a Lipid Nano-Crystal (LNC) drug delivery platform that enables oral, intracellular delivery of small molecules and oligonucleotides. Its lead product MAT2203 is an amphotericin B formulation, alongside discovery programs in oncology and inflammation.
0 investors
Maykr is a holding company and investment platform that acquires and partners with operating companies at the intersection of AI, infrastructure, and industrial technology. It builds enterprise value through capital, operational support, and strategic expansion, with operating companies and a portfolio spanning AI, energy, healthcare, and applied intelligence.
0 investors
Mechnano develops additive manufacturing materials that incorporate discrete, dispersed, and functionalized carbon nanotubes (dCNT) to improve properties such as static dissipation, impact resistance, tear resistance, and tensile strength. It supplies high-performance 3D printing materials for industries needing more reliable and economical parts.
0 investors
Melior Innovations develops materials technologies designed to address market needs across various industries. The company focuses on creating disruptive solutions through a culture emphasizing innovation and market application.
0 investors
MicroVision develops lidar and perception systems for automotive OEMs, supporting autonomous driving and advanced driver-assistance systems. The company focuses on scaling these hardware technologies from R&D to commercial products for the mobility sector.
0 investors
MIIR Audio Tech develops audio technology, with a team combining engineering and neuroscience/science advisory expertise. The company's product involves proprietary inventions in the audio space.
0 investors
MIVI develops medical devices to improve outcomes in neurointerventional procedures, specifically targeting aspiration in distal stroke occlusions and reducing distal embolization during mechanical thrombectomy.
0 investors
Mixed-Signal Devices builds an all-digital, CMOS-based precision timing platform, including oscillators and clock-generation technology, that replaces legacy analog clock chains with multi-gigahertz timing and sub-20 femtosecond jitter. Its clocks target AI infrastructure and GPU fabrics, 5G base stations, and automotive systems such as radar and ADAS.
0 investors
Modulate Bio develops small-molecule GABAA positive allosteric modulators to treat neurological disorders including Essential Tremor, epilepsy, and anxiety. Its drug-discovery platform aims to selectively activate specific GABAA receptor subunits to provide efficacy while limiting side effects.
0 investors
Molecular Vista builds nano-IR microscopes (the Vista series/VistaScope) using photo-induced force microscopy (PiFM) and photo-induced force IR spectroscopy (PiF-IR) for nanoscale chemical analysis. It sells these instruments and offers contract analysis services to researchers working in materials science, chemistry, physics, and semiconductor analysis.
0 investors
MyFloraDNA is a biotechnology company providing genomic testing products, services, and education for the cannabis industry. It serves growers worldwide, aiming to help improve crop yields, quality, and sustainability through access to genomic sciences.
0 investors
Myosana Therapeutics develops non-viral, muscle-targeted gene therapies aimed at slowing skeletal muscle degeneration and heart failure in Duchenne muscular dystrophy (DMD) and other neuromuscular and cardiac diseases. The company works in the biotech and gene therapy field.
0 investors
Myrtelle develops gene therapies for neurological diseases, particularly white matter disorders of the central nervous system. The company is conducting clinical trials for Canavan disease using novel AAV vector technology to target oligodendrocytes.
0 investors
Nabsys develops genome mapping technology for genomic structural variant analysis, enabling precision and cost-effectiveness in this field. The company serves research and clinical customers globally.
0 investors
NANO Nuclear Energy is a vertically integrated company developing advanced portable microreactor technology, including the KRONOS MMR, spanning reactor design, safety analysis, fuel cycle facilities, and licensing. Publicly listed on NASDAQ, it serves the advanced nuclear energy sector.
0 investors
NanobOx develops nanobubble technology based on a patented electric field method for use in agriculture, aquaculture, and other biological applications. The Ireland-based company applies its deep-tech solutions to biological and agricultural markets.
0 investors
NanoGuard Technologies is a deep-technology company developing High Voltage Atmospheric Cold Plasma treatment technology and its applications. It works across scientific, technical, and commercial disciplines to evaluate application needs based on data.
0 investors
Nanoscale Powders manufactures high-purity metal powders including titanium, refractory metals, and silicon alloys using proprietary processes for aerospace, energy, and battery applications. The company serves industrial customers in advanced materials sectors.
0 investors
NantOptiFab produces thin film lithium niobate (TFLN) and silicon wafers in-house and fabricates photonic chips and devices for telecom, AI interconnects, defense, and quantum applications. The company operates its own electro-optics fabrication facilities in California with a fully US-based supply chain.
0 investors
Navega Therapeutics develops gene therapies using zinc-finger and CRISPR-based epigenome regulation to control gene expression. The company works in the biotech and gene therapy space.
0 investors
Navrogen is a biopharmaceutical company developing therapeutic agents that counter tumor-produced Humoral Immuno-Oncology (HIO) factors linked to suppressed humoral immunity and poor response to immune-mediated anti-cancer therapies. It uses proprietary screening, antibody engineering technologies, and diagnostic assays to identify patients whose tumors produce HIO factors, targeting cancer and immune-related disorders.
0 investors
Nebula Space Enterprise, Inc. focuses on space exploration and access to deep-space resources, operating through five entities spanning blockchain, cybersecurity, computing, an incubator, and media.
0 investors
Neuroelectrics develops the Starstim platform, combining EEG monitoring headpieces, cloud-based delivery, and personalized protocols to deliver non-invasive Transcranial Electrical Stimulation (tES) neuromodulation therapy for brain disorders such as depression and epilepsy. It serves patients whose conditions are not controlled by drugs or surgery, as well as neuroscience researchers who use its tools for brain research.
0 investors
NeuroEM Therapeutics develops MemorEM, a wearable head device that administers transcranial electromagnetic treatment to treat cognitive decline and Alzheimer's disease. The device targets patients with neurodegenerative diseases through a non-invasive, in-home treatment delivered by healthcare professionals.
0 investors